Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

Despite a Q1 revenue miss due to currency headwinds, core EPS beat expectations for AstraZeneca. Read why AZN stock is a Buy.

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

Page, whose legal name was Kylie Pylant, had been taking her AA meetings seriously and even stepped up to lead some sessions ...

Prices are falling for the popular obesity treatments semaglutide (Wegovy) and tirzepatide (Zepbound), but steady access to the drugs remains challenging. The medications still amount to around $500 ...

The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

He posed as a mobster dealing drugs and laundering cash to help topple Nicky Barnes, who as “Mr. Untouchable” ran a formidable Harlem heroin ring. By Sam Roberts June 20, 2025 Page 1 of 10 1 2 ...

Personalized Medicine New Oral Anticoagulant Drugs Real-World Data Omer Iqbal Disclosures Personalized Medicine. 2013;10 (5):419-422. ... Approval of New Oral Anticoagulant Drugs ...

Nanomedicine Self-nanoemulsifying Drug Delivery Systems: Formulation Insights, Applications and Advances ...

The new drugs “cover a major unmet need: obesity was one of the only chronic diseases for which there were few medications,” French endocrinologist Emmanuel Disse told AFP. During clinical trials, the ...

The new drugs "cover a major unmet need: obesity was one of the only chronic diseases for which there were few medications," French endocrinologist Emmanuel Disse told AFP. During clinical trials, the ...